Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase NA 3Phase 1 2Phase 4 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Tumor Response Rate 1Hepatic Malignancies 1Carcinoma, Hepatocellular 1

Interventions

Exercise 419Blood Specimen Collection 319Standard of Care 299Surveys and Questionnaires 242Radiosurgery 239Magnetic Resonance Spectroscopy 232Educational Status 223Methods 221Radiotherapy 216Early Intervention, Educational 200Interviews as Topic 142Practice Guidelines as Topic 141Biopsy 125Surgical Procedures, Operative 119Drug Therapy 119Acupuncture Therapy 119Control Groups 115Therapeutics 101Palliative Care 97Resistance Training 94Counseling 88Saline Solution 87Magnetic Resonance Imaging 84Cyclophosphamide 83Specimen Handling 73Cisplatin 73Radiofrequency Ablation 71Cognitive Behavioral Therapy 71Radiotherapy, Intensity-Modulated 68Colonoscopy 65

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × OTHER × Sirtuins × Clear all
NCT05994859 2023-09-14

SIRT for Potentially Resectable HCC

Second Affiliated Hospital of Guangzhou Medical University

Phase NA Recruiting
35 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT04332419 2022-06-22

Comparison of Yttrium-90 Absorbed Doses Using PET/CT Versus PET/MR Imaging for Hepatic Malignancies

Case Comprehensive Cancer Center

Phase NA Completed
11 enrolled 7 charts

Hepatic Malignancies

NCT03910140 2019-04-10

TILA-TACE in Treatment of Hepatocellular Carcinoma

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase NA Unknown
2,000 enrolled

Tumor Response Rate

Data powered by HemOnc (CC BY 4.0) Colophon âš¡